Hudson Capital Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
ECSS
ATO
Hudson Capital Management's MRK Position: Q2 2026 in Review
Hudson Capital Management increased its Merck (MRK) stake by 0.64% in Q2 2026, buying an estimated $1.64K and bringing the position to 2,196 shares worth $282K. The position accounts for 0.07% of the portfolio, ranked #66.
Hudson Capital Management first reported a position in MRK in Q4 2017 and has held it in 18 quarters since. The position peaked at $730K in Q1 2019. 1,613 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Hudson Capital Management held 2,196 shares of Merck worth $282K as of Q2 2026.
- Hudson Capital Management bought 14 Merck shares in Q2 2026, an estimated $1.64K.
- Merck made up 0.07% of Hudson Capital Management's portfolio in Q2 2026, its #66 holding.
- Hudson Capital Management first reported a position in Merck in Q4 2017 and has held it in 18 quarters since.
- Hudson Capital Management's Merck position peaked at $730K in Q1 2019.
- 1,613 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Hudson Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.